ArticleMikrochimica acta2026
Colorimetric and luminescent detection of cysteamine based on lanthanide-doped upconversion nanoparticles and gold nanoparticles.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
A colorimetric/luminescent detection nanoprobe based on polyacrylic acid (PAA)-modified lanthanide-doped upconversion nanoparticles (PAA-UCNPs) and gold nanoparticles (AuNPs) is prepared for cysteamine detection. PAA-UCNPs (NaYF4:Yb,Er@NaYF4) exhibit green and red emission under near-infrared laser excitation. In the presence of cysteamine, citrate-stabilized AuNPs aggregate, causing a significant red shift in their absorption peak and weakening the red luminescence of PAA-UCNPs based on the inner filter effect (IFE). This nanoprobe enables rapid (5 min) and precise determination of cysteamine, with a wide linear range (0.1–1.0 µM in colorimetric mode and 0.25–1.25 µM in luminescence mode) and a low detection limit (44.4 nM in colorimetric mode and 23.3 nM in luminescence mode). Moreover, this dual-mode method is used for cysteamine detection in calf serum, demonstrating high sensitivity and reproducibility.
Indexed as
Identifiers
41483319What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.